The impact of the COVID-19 pandemic on processes, resource use and cost in palliative care.

Cost comparison Costs Covid-19 Palliative care Pandemic Quality of care Resource comparison Resources

Journal

BMC palliative care
ISSN: 1472-684X
Titre abrégé: BMC Palliat Care
Pays: England
ID NLM: 101088685

Informations de publication

Date de publication:
06 Apr 2023
Historique:
received: 14 06 2022
accepted: 24 03 2023
medline: 10 4 2023
entrez: 6 4 2023
pubmed: 7 4 2023
Statut: epublish

Résumé

The COVID-19 pandemic impacts on working routines and workload of palliative care (PC) teams but information is lacking how resource use and associated hospital costs for PC changed at patient-level during the pandemic. We aim to describe differences in patient characteristics, care processes and resource use in specialist PC (PC unit and PC advisory team) in a university hospital before and during the first pandemic year. Retrospective, cross-sectional study using routine data of all patients cared for in a PC unit and a PC advisory team during 10-12/2019 and 10-12/2020. Data included patient characteristics (age, sex, cancer/non-cancer, symptom/problem burden using Integrated Palliative Care Outcome Scale (IPOS)), information on care episode, and labour time calculated in care minutes. Cost calculation with combined top-down bottom-up approach with hospital's cost data from 2019. Descriptive statistics and comparisons between groups using parametric and non-parametric tests. Inclusion of 55/76 patient episodes in 2019/2020 from the PC unit and 135/120 episodes from the PC advisory team, respectively. IPOS scores were lower in 2020 (PCU: 2.0 points; PC advisory team: 3.0 points). The number of completed assessments differed considerably between years (PCU: episode beginning 30.9%/54.0% in 2019/2020; PC advisory team: 47.4%/40.0%). Care episodes were by one day shorter in 2020 in the PC advisory team. Only slight non-significant differences were observed regarding total minutes/day and patient (PCU: 150.0/141.1 min., PC advisory team: 54.2/66.9 min.). Staff minutes showed a significant decrease in minutes spent in direct contact with relatives (PCU: 13.9/7.3 min/day in 2019/2020, PC advisory team: 5.0/3.5 min/day). Costs per patient/day decreased significantly in 2020 compared to 2019 on the PCU (1075 Euro/944 Euro for 2019/2020) and increased significantly for the PC advisory team (161 Euro/200 Euro for 2019/2020). Overhead costs accounted for more than two thirds of total costs. Direct patient cost differed only slightly (PCU: 134.7 Euro/131.1 Euro in 2019/2020, PC advisory team: 54.4 Euro/57.3 Euro). The pandemic partially impacted on daily work routines, especially on time spent with relatives and palliative care problem assessments. Care processes and quality of care might vary and have different outcomes during a crisis such as the COVID-19 pandemic. Direct costs per patient/day were comparable, regardless of the pandemic.

Sections du résumé

BACKGROUND BACKGROUND
The COVID-19 pandemic impacts on working routines and workload of palliative care (PC) teams but information is lacking how resource use and associated hospital costs for PC changed at patient-level during the pandemic. We aim to describe differences in patient characteristics, care processes and resource use in specialist PC (PC unit and PC advisory team) in a university hospital before and during the first pandemic year.
METHODS METHODS
Retrospective, cross-sectional study using routine data of all patients cared for in a PC unit and a PC advisory team during 10-12/2019 and 10-12/2020. Data included patient characteristics (age, sex, cancer/non-cancer, symptom/problem burden using Integrated Palliative Care Outcome Scale (IPOS)), information on care episode, and labour time calculated in care minutes. Cost calculation with combined top-down bottom-up approach with hospital's cost data from 2019. Descriptive statistics and comparisons between groups using parametric and non-parametric tests.
RESULTS RESULTS
Inclusion of 55/76 patient episodes in 2019/2020 from the PC unit and 135/120 episodes from the PC advisory team, respectively. IPOS scores were lower in 2020 (PCU: 2.0 points; PC advisory team: 3.0 points). The number of completed assessments differed considerably between years (PCU: episode beginning 30.9%/54.0% in 2019/2020; PC advisory team: 47.4%/40.0%). Care episodes were by one day shorter in 2020 in the PC advisory team. Only slight non-significant differences were observed regarding total minutes/day and patient (PCU: 150.0/141.1 min., PC advisory team: 54.2/66.9 min.). Staff minutes showed a significant decrease in minutes spent in direct contact with relatives (PCU: 13.9/7.3 min/day in 2019/2020, PC advisory team: 5.0/3.5 min/day). Costs per patient/day decreased significantly in 2020 compared to 2019 on the PCU (1075 Euro/944 Euro for 2019/2020) and increased significantly for the PC advisory team (161 Euro/200 Euro for 2019/2020). Overhead costs accounted for more than two thirds of total costs. Direct patient cost differed only slightly (PCU: 134.7 Euro/131.1 Euro in 2019/2020, PC advisory team: 54.4 Euro/57.3 Euro).
CONCLUSIONS CONCLUSIONS
The pandemic partially impacted on daily work routines, especially on time spent with relatives and palliative care problem assessments. Care processes and quality of care might vary and have different outcomes during a crisis such as the COVID-19 pandemic. Direct costs per patient/day were comparable, regardless of the pandemic.

Identifiants

pubmed: 37024852
doi: 10.1186/s12904-023-01151-2
pii: 10.1186/s12904-023-01151-2
pmc: PMC10077306
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

36

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s).

Références

Palliat Med. 2021 May;35(5):814-829
pubmed: 33754892
Palliat Med. 2017 Apr;31(4):323-337
pubmed: 27670418
Palliat Med. 2004 Apr;18(3):217-26
pubmed: 15198134
Cost Eff Resour Alloc. 2018 Oct 16;16:35
pubmed: 30349423
Palliat Med. 2021 Sep;35(8):1492-1501
pubmed: 34296637
Int J Nurs Stud. 2021 Sep;121:104000
pubmed: 34242976
Palliat Support Care. 2021 Apr;19(2):187-192
pubmed: 33648620
J Palliat Med. 2022 Mar;25(3):465-471
pubmed: 34935477
Palliat Med. 2019 Sep;33(8):1045-1057
pubmed: 31185804
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
BMC Palliat Care. 2018 Apr 5;17(1):58
pubmed: 29622004
J Pain Symptom Manage. 2014 Oct;48(4):719-29
pubmed: 24709365
CMAJ. 2020 Apr 14;192(15):E400-E404
pubmed: 32234725
Palliat Med. 2022 Apr;36(4):708-716
pubmed: 35350933
BJGP Open. 2021 Aug 24;5(4):
pubmed: 34117014

Auteurs

Farina Hodiamont (F)

Department of Palliative Medicine, University Hospital, LMU Munich, Munich, Germany. farina.hodiamont@med.uni-muenchen.de.

Caroline Schatz (C)

Helmholtz Zentrum München, Institute of Health Economics and Health Care Management, Munich, Germany.
Ludwig-Maximilians-Universität München, LMU Munich School of Management, Institute of Health Economics and Health Care Management, Munich, Germany.

Eva Schildmann (E)

Department of Palliative Medicine, University Hospital, LMU Munich, Munich, Germany.
Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Department of Hematology, Oncology and Cancer Immunology, Oncological Palliative Care & Charité Comprehensive Cancer Center, Berlin, Germany.

Zulfiya Syunyaeva (Z)

Charité Universitätsmedizin Berlin, Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine and Cystic Fibrosis Center, Berlin, Germany.

Katerina Hriskova (K)

Department of Palliative Medicine, University Hospital, LMU Munich, Munich, Germany.

Constanze Rémi (C)

Department of Palliative Medicine, University Hospital, LMU Munich, Munich, Germany.

Reiner Leidl (R)

Helmholtz Zentrum München, Institute of Health Economics and Health Care Management, Munich, Germany.
Ludwig-Maximilians-Universität München, LMU Munich School of Management, Institute of Health Economics and Health Care Management, Munich, Germany.

Susanne Tänzler (S)

Department of Palliative Medicine, University Hospital, LMU Munich, Munich, Germany.

Claudia Bausewein (C)

Department of Palliative Medicine, University Hospital, LMU Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH